Year in review 2023 – Back to the future
- 1 March 2024
- journal article
- review article
- Published by Elsevier in Journal of Cystic Fibrosis
- Vol. 23 (2) , 203-207
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: Results from the CLIMB‐CF studyPediatric Pulmonology, 2023
- Effect of Hypertonic Saline on Lung Function as Add-on Treatment in People With Cystic Fibrosis Receiving Dornase AlfaChest, 2023
- FDA-approved drug screening in patient-derived organoids demonstrates potential of drug repurposing for rare cystic fibrosis genotypesJournal of Cystic Fibrosis, 2023
- A multidisciplinary model for prenatal care for patients with cystic fibrosis in the era of highly effective modulator therapyJournal of Cystic Fibrosis, 2023
- Real-world safety and effectiveness of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis: Interim results of a long-term registry-based studyJournal of Cystic Fibrosis, 2023
- Position paper: Models of post-transplant care for individuals with cystic fibrosisJournal of Cystic Fibrosis, 2023
- Elexacaftor/tezacaftor/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508delJournal of Cystic Fibrosis, 2023
- Exhaled breath profiles to detect lung infection with Staphylococcus aureus in children with cystic fibrosisJournal of Cystic Fibrosis, 2023
- Prevalence, trends and outcomes of long-term inhaled antibiotic treatment in people with cystic fibrosis without chronic Pseudomonas aeruginosa infection – A European cystic fibrosis patient registry data analysisJournal of Cystic Fibrosis, 2022
- Impact of antibiotic eradication therapy of Pseudomonas aeruginosa on long term lung function in cystic fibrosisJournal of Cystic Fibrosis, 2022